SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: gonnahappensoon who wrote (8111)10/31/2009 7:30:00 AM
From: erickerickson4 Recommendations  Read Replies (1) | Respond to of 63329
 
<<<That is what is killing the stock...they failed to raise money when the sector was hot and their share price was at a recent high>>>

I seriously doubt that. You're implying that IMMU could have gone out there and found someone willing to part with, say, $100M during its rise. A rise fueled not by some actual approval, but riding the coat-tails of HGSI. It's not that easy.

Say what you will about HGSI, they *did* have real news in hand, approval of their product, to entice investors into their secondary. Which makes it far easier to raise money.

And $6 was too low for IMMU to think about raising cash anyway <G>..

Best
Erick



To: gonnahappensoon who wrote (8111)10/31/2009 3:22:59 PM
From: Rickles12 Recommendations  Respond to of 63329
 
gonna: If IMMU management sincerely believed the stock price would be 12 in February rather than 6 in August, why shouldn't they wait?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News